References
Dalmau J, Rosenfeld MR (2008) Paraneoplastic syndromes of the CNS. Lancet Neurol 7(4):327–40
Psimaras D, Carpentier AF, Rossi C (2010) Cerebrospinal fluid study in paraneoplastic syndromes. PNS Euronetwork J Neurol Neurosurg Psychiatry 81(1):42–5
Kannoth S (2012) Paraneoplastic neurologic syndrome: a practical approach. Ann Ind Acad Neurol 15(1):6–12
Honnorat J, Cartalat-Carel S (2004) Advances in paraneoplastic neurological syndromes. Curr Opin Oncol 16(6):614–20, Review
Trotter JL, Hendin BA, Osterland CK (1976) Cerebellar degeneration with Hodgkin disease. An immunological study. Arch Neurol 33(9):660–1
Graus F, Gultekin SH, Ferrer I, Reiriz J, Alberch J, Dalmau J (1998) Localization of the neuronal antigen recognized by anti-Tr antibodies from patients with paraneoplastic cerebellar degeneration and Hodgkin’s disease in the rat nervous system. Acta Neuropathol 96(1):1–7
Bernal F, Shams'ili S, Rojas I, Sanchez-Valle R, Saiz A, Dalmau J et al (2003) Anti-Tr antibodies as markers of paraneoplastic cerebellar degeneration and Hodgkin’s disease. Neurology 60:230–4
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Statement
This retrospective patient case study has been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. All procedures followed in this study were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008.
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Chepovetsky, J., Duffield, A.S. & Pu, J.J. Paraneoplastic cerebellar degeneration as an early sign of classical Hodgkin lymphoma. Ann Hematol 95, 511–513 (2016). https://doi.org/10.1007/s00277-015-2542-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-015-2542-5